CSRxP STATEMENT ON PCMA LAWSUIT CHALLENGING TRUMP ADMINISTRATION’S REBATE RULE
Misguided Policy Published in Violation of Legally Required Process for Public… Read More
© 2026 CSRXP- All Rights Reserved
BIG PHARMA WATCH: HEADLINES FROM BIG PHARMA’S NEW YEAR PRICE HIKES
Second Major Round of Pandemic Price Increases Underscores Urgency for… Read More
HAPPY NEW YEAR: BIG PHARMA HIKES PRICES ON MORE THAN 580 RX DRUGS TO START 2021
Drug Companies Double Down In Second Major Round Of Pandemic Price Hikes As… Read More
“DOSE OF REALITY” BIG PHARMA’S YEAR OF BAD BEHAVIOR
Part IV: Escalating Assault on 340B Program for Providers Serving America’s… Read More
“DOSE OF REALITY” BIG PHARMA’S YEAR OF BAD BEHAVIOR
Part III: Angling to Price-Gouge American Public on COVID-19 Treatments… Read More
“DOSE OF REALITY” BIG PHARMA’S YEAR OF BAD BEHAVIOR
Part II: Gaming the System to Undermine Competition at the Expense of American… Read More
“DOSE OF REALITY” BIG PHARMA’S YEAR OF BAD BEHAVIOR
Part I: Sticking with Price-Hiking “Business-as-Usual” During Pandemic… Read More
TWO BIRDS OF A FEATHER: ASTRAZENECA TO ACQUIRE FELLOW PRICE-GOUGER ALEXION IN MULTI-BILLION DOLLAR DEAL
In case you missed it, Big Pharma giant AstraZeneca announced plans to acquire… Read More
CSRXP STATEMENT ON SELECTION OF XAVIER BECERRA FOR THE U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES
Campaign Looks Forward to Working with Becerra to Lower Drug Prices… Read More
CSRXP: BIG PHARMA MUST BE HELD ACCOUNTABLE FOR ESCALATING ASSAULT ON CRITICAL 340B PROGRAM
Novo Nordisk Becomes Latest Drug Company to Dodge Requirement to Provide… Read More
CSRxP: MISGUIDED REBATE RULE A BIG PHARMA BAILOUT PAID FOR BY AMERICAN SENIORS & TAXPAYERS
Rebate Rule Will Increase Premiums for Medicare Part D Beneficiaries… Read More
REMINDER: REBATE RULE WOULD DO NOTHING TO LOWER DRUG PRICES WHILE HIKING PREMIUMS ON SENIORS AND COSTING TAXPAYERS $200 BILLION
Administration Should Abandon Misguided Policy That Rewards Drug Companies’… Read More